Abstract Objective: Thyroid cancer (THCA) is the most common endocrine cancer in the world. Although most patients with THCA have…
Abstract Thyroid carcinoma (TC) is the most common malignancy of endocrine organs. The cell subpopulation in the lineage hierarchy that…
Abstract Cuproptosis is a novel programmed cell death that depends on copper. The role and potential mechanism of cuproptosis-related genes…
Abstract Background: Epigenetic reprogramming has been reported to play a critical role in the progression of thyroid cancer. RNA methylation…
Abstract The abnormal expression of chordin-like 1 (CHRDL1) is identified in many cancers, while the effect of CHRDL1 in thyroid…
Abstract Introduction: Cellular senescence is a hallmark of tumors and has potential for cancer therapy. Cellular senescence of tumor cells…
Abstract Metabolic reprogramming is one of the cancer hallmarks, important for the survival of malignant cells. We investigated the prognostic…
Abstract Objective: To explore the regulatory mechanism of immune prognostic factors in thyroid cancer. Methods: Based on the TCGA database…
Abstract Introduction: Immune checkpoint inhibitors (ICIs) have shown promising results for the treatment of multiple cancers. ICIs and related therapies…
Abstract Simple Summary: Thyroid cancer is the most common endocrine cancer and the treatment for such hostile tumors remains a…